4055380
Performance-enhancing drugs: Understanding the risks
To help clinicians understand the risks associated with performance-enhancing drugs, this overview covers prohibited lists of substances and methods, therapeutic use exemptions, the legitimate indications and adverse effects, including for megadose and polypharmacy doping of stimulants, anabolic steroids, erythropoiesis-stimulating agents, and growth hormone and ways in which physicians or patients risk committing anti-doping rule violations inadvertently.
© Copyright 2014 Physical Medicine & Rehabilitation Clinics of North America. Elsevier. All rights reserved.
| Subjects: | |
|---|---|
| Notations: | biological and medical sciences theory and social foundations |
| Tagging: | Steroid Wachstumshormon |
| Published in: | Physical Medicine & Rehabilitation Clinics of North America |
| Language: | English |
| Published: |
2014
|
| Online Access: | https://doi.org/10.1016/j.pmr.2014.06.013 |
| Volume: | 25 |
| Issue: | 4 |
| Pages: | 897-913 |
| Document types: | article |
| Level: | advanced |